XML 120 R96.htm IDEA: XBRL DOCUMENT v3.25.0.1
SCHEDULE II - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 762,994 $ 712,949 $ 865,349
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred tax (benefit) expense 1,805 1,550 (5,235)
Loss on debt extinguishment 0 0 40,199
Change in certain assets and liabilities:      
Accrued investment income (2,290) (3,596) (3,276)
Net cash provided by operating activities 725,032 712,962 650,012
Cash flows from investing activities:      
Purchases of investments (1,555,624) (1,469,540) (674,406)
Proceeds from sales of investments 45,087 376,598 399,661
Net cash (used in) provided by investing activities (142,005) (179,190) 410,485
Cash flows from financing activities:      
Conversion / purchase of convertible junior subordinated debentures 0 (28,637) (89,118)
Redemption of 5.75% senior notes 0 0 (242,296)
Cash portion of loss on debt extinguishment 0 0 (39,514)
Repurchase of common stock (569,478) (337,182) (385,573)
Dividends paid (130,500) (122,965) (110,947)
Payment of withholding taxes related to share-based compensation net share settlement (19,066) (7,257) (10,094)
Net cash used in financing activities (719,044) (496,041) (1,032,542)
Net (decrease) increase in cash and cash equivalents and restricted cash and cash equivalents (136,017) 37,731 27,955
Cash and cash equivalents and restricted cash and cash equivalents at beginning of year 370,644 332,913 304,958
Cash and cash equivalents and restricted cash and cash equivalents at end of year 234,627 370,644 332,913
Parent Company      
Cash flows from operating activities:      
Net income 762,994 712,949 865,349
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity in net income of subsidiaries (752,882) (719,599) (930,979)
Dividends received from subsidiaries 526,879 326,013 626,695
Deferred tax (benefit) expense 36,798 86,219 119,588
Loss on debt extinguishment 0 0 38,870
Other 19,298 26,726 33,619
Change in certain assets and liabilities:      
Accounts receivable - affiliates 348 (1,996) 1,266
Income taxes receivable (5,683) 45,913 (43,123)
Accrued investment income 1,007 (499) 931
Accrued interest 0 349 (7,230)
Net cash provided by operating activities 588,759 476,075 704,986
Cash flows from investing activities:      
Return of capital from subsidiaries 40,000 0 0
Purchases of investments (514,482) (566,795) (1,457)
Proceeds from sales of investments 546,111 555,957 287,924
Net cash (used in) provided by investing activities 71,629 (10,838) 286,467
Cash flows from financing activities:      
Conversion / purchase of convertible junior subordinated debentures 0 (28,637) (89,118)
Redemption of 5.75% senior notes 0 0 (242,296)
Cash portion of loss on debt extinguishment 0 0 (38,185)
Repurchase of common stock (569,478) (337,182) (385,573)
Dividends paid (130,500) (122,965) (110,947)
Payment of withholding taxes related to share-based compensation net share settlement (19,066) (7,257) (10,094)
Net cash used in financing activities (719,044) (496,041) (876,213)
Net (decrease) increase in cash and cash equivalents and restricted cash and cash equivalents (58,656) (30,804) 115,240
Cash and cash equivalents and restricted cash and cash equivalents at beginning of year 208,600 239,404 124,164
Cash and cash equivalents and restricted cash and cash equivalents at end of year $ 149,944 $ 208,600 $ 239,404